Malformations Surveillance: Comparison between Findings at Birth and Age 1 Year

Emma G Thomas1,2, Cathleen Higgins3, Marie-Noel Westgate1,2

  • 1Active Malformations Surveillance Program, Department of Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Birth Defects Research
|August 11, 2017
PubMed

Insights

Congenital anomaly surveillance missed 3.5% of newborn malformations at birth. Continued follow-up in the first year is crucial for accurate detection of birth defects.

Area of Science:

  • Medical Surveillance
  • Neonatal Care
  • Public Health

Background:

  • Congenital anomalies affect newborn infants, necessitating robust surveillance programs.
  • Accurate prevalence data for birth defects is essential for public health initiatives.
  • Comparing early detection with later findings can reveal surveillance system limitations.

Purpose of the Study:

  • To evaluate the effectiveness of newborn malformation surveillance programs.
  • To identify congenital anomalies missed at birth but detected later in infancy.
  • To improve the accuracy and completeness of birth defect monitoring.

Main Methods:

  • Compared malformations identified at birth by Brigham and Women's Hospital (BWH) with those detected up to age 1 year by the Massachusetts Birth Defects Monitoring Program.
  • Analyzed data from the years 2000 and 2005 for a cohort of newborn infants.
  • Investigated reasons for missed or delayed detection of congenital anomalies.

Main Results:

  • 3.5% of malformed infants were missed at birth by the BWH Surveillance Program.
  • An additional 2.3% of malformed infants had delayed detection within the first year.
  • Mild heart defects, such as atrial septal defects, were commonly detected later.

Conclusions:

  • Newborn malformation surveillance requires continued follow-up beyond the initial examination.
  • Physician documentation and review of findings are critical for accurate surveillance.
  • Enhanced follow-up is particularly important for small, premature infants to detect all congenital anomalies.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Physical Growth During Infancy and Toddlerhood01:18

Physical Growth During Infancy and Toddlerhood

Physical growth is especially rapid during the first three years of life, with the greatest rate in the first few months after birth. Although children continue to gain height and weight throughout infancy and toddlerhood, the rate of growth gradually slows during the second and third years. At most ages, boys are typically slightly taller and heavier than girls, reflecting a common pattern of early physical development.Changes in Body ProportionsAs infants become toddlers, their body...
Vision During Infancy and Toddlerhood01:23

Vision During Infancy and Toddlerhood

At birth, vision is the least developed of the major senses because the visual system is still structurally and neurologically immature. The retinas, optic nerves, and visual regions of the brain continue to mature after birth. As a result, newborns have limited visual acuity, or sharpness and clarity of vision, and respond best to objects viewed at close range, roughly 8 to 12 inches away.Rapid Visual DevelopmentVision improves rapidly during the first few months as infants observe and...